Publicaciones en colaboración con investigadores/as de University of Amsterdam (50)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx (Nature, (2023), 616, 7957, (525-533), 10.1038/s41586-023-05783-5)

    Nature

  3. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

    The Lancet HIV, Vol. 11, Núm. 2, pp. e106-e116

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study

    European Journal of Surgical Oncology, Vol. 50, Núm. 6

  6. Is prolonged operative time associated with postoperative complications in liver surgery? An international multicentre cohort study of 5424 patients

    Surgical Endoscopy

  7. Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study

    British Journal of Surgery, Vol. 111, Núm. 8

  8. Robotic Versus Laparoscopic Liver Resection in Various Settings: An International Multicenter Propensity Score Matched Study of 10.075 Patients

    Annals of Surgery, Vol. 280, Núm. 1, pp. 108-117

  9. Trends in the characteristics and perioperative outcomes of patients undergoing laparoscopic and open resections for benign liver lesions: An international multicenter retrospective cohort study of 845 patients

    HPB, Vol. 26, Núm. 2, pp. 188-202

2023

  1. An International Expert Delphi Consensus on Defining Textbook Outcome in Liver Surgery (TOLS)

    Annals of Surgery, Vol. 277, Núm. 5, pp. 821-828

  2. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial

    JHEP Reports, Vol. 5, Núm. 5

  3. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial

    HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6

  4. Minimally invasive versus open liver resection for hepatocellular carcinoma in the elderly: international multicentre propensity score-matched study

    British Journal of Surgery, Vol. 110, Núm. 8, pp. 927-930

  5. Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression

    European Radiology, Vol. 33, Núm. 1, pp. 493-500

  6. Protective ileostomy creation after anterior resection of the rectum: Shared decision-making or still subjective?

    Colorectal Disease, Vol. 25, Núm. 4, pp. 647-659

  7. Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients

    Seminars in Hematology

  8. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

    Seminars in Hematology

  9. Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials

    Seminars in Hematology

  10. Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer

    World Journal of Men's Health

  11. Simultaneous resection of colorectal cancer and synchronous liver metastases: what determines the risk of unfavorable outcomes? An international multicenter retrospective cohort study

    International journal of surgery (London, England), Vol. 109, Núm. 3, pp. 244-254